News | Wearables | April 12, 2022

New Fitbit Feature Makes AFib Detection More Accessible

Fitbit received clearance from the U.S. Food and Drug Administration for our new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power our new Irregular Heart Rhythm Notifications feature on Fitbit.

April 12, 2022 — Fitbit received clearance from the U.S. Food and Drug Administration for its new PPG (photoplethysmography) algorithm to identify atrial fibrillation (AFib). The algorithm will power its new Irregular Heart Rhythm Notifications feature on Fitbit.1

You’ve got rhythm, but is it irregular?

AFib is a form of irregular heart rhythm that affects nearly 33.5 million people globally, and individuals with AFib have five times higher risk of stroke. Unfortunately, AFib can be difficult to detect as there are often no symptoms and episodes can come and go.

The new PPG AFib algorithm can passively assess your heart rhythm in the background while you’re still or asleep. If there’s anything that might be suggestive of AFib, you’ll be notified through our Irregular Heart Rhythm Notifications feature — allowing you to talk with your healthcare provider or seek further assessment to help prevent a significant medical event, such as stroke.

So how does PPG AFib detection work?

When your heart beats, tiny blood vessels throughout your body expand and contract based on changes in blood volume. Fitbit’s PPG optical heart-rate sensor can detect these volume changes right from your wrist. These measurements determine your heart rhythm, which the detection algorithm then analyzes for irregularities and potential signs of atrial fibrillation.

The clinical validation for Fitbit’s PPG algorithm is supported by data from the landmark Fitbit Heart Study, which launched in 2020 and enrolled 455,699 participants over five months. The study was conducted entirely virtually during the pandemic, making it one of the largest remote studies of PPG-based software to date. Data presented at the 2021 American Heart Association Scientific Sessions found that the Fitbit PPG detections correctly identified AFib episodes 98% of the time, as confirmed by ECG patch monitors.

Because AFib can be so sporadic, the optimal way to screen for it is through heart rate tracking technology when the body is still or at rest — making overnight detection when people are asleep especially important. The unique capabilities of Fitbit devices — especially its 24/7 heart rate tracking and long battery life — give it the potential to accelerate identification through long-term heart rhythm assessment.

All the ways to monitor heart health with Fitbit

With the FDA clearance of our PPG-based algorithm, Fitbit now provides two ways to detect AFib. Fitbit’s ECG app, which takes a spot-check approach, allows you to proactively screen yourself for possible AFib and record an ECG trace that you can then review with a healthcare provider. Additionally, the new PPG-based algorithm allows for long-term heart rhythm assessment that helps identify asymptomatic AFib that could otherwise go undetected.

The Fitbit PPG-based algorithm and Irregular Heart Rhythm Notifications feature will soon be available to consumers in the U.S. across a range of heart-rate enabled devices. We want to make AFib detection as accessible as possible to help reduce the risk of potentially life-threatening events — like stroke — and ultimately improve overall heart health for everyone. We’ll continue to work with the BMS-Pfizer Alliance to develop educational content for patients and healthcare providers that will help identify and support people in the U.S. with irregular heart rhythms consistent with atrial fibrillation.

For more information: https://www.fitbit.com/

Related Content on Wearables and Big Data in Healthcare:

Tracking Cardiovascular Health Population Trends Using Consumer Wearables

Bristol-Myers Squibb-Pfizer Alliance, Fitbit Team Up on Atrial Fibrillation Detection

Artificial Intelligence Detects AFib Using Apple Watch Heart Rate Sensor

Consumer Smart Watches Accurately Measure Paroxysmal Supraventricular Tachycardia

VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — Interview with Robert Klempfner, M.D.

VIDEO: Mobile App Links Wearable Data to Electronic Medical Records

Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation

VIDEO: Use of Wearables to Track Electrophysiology Patients — Interview with Khaldoun Tarakji, M.D.

VIDEO: The Future of Wearables in Healthcare — Karl Poterack, M.D.

8 Cardiovascular Technologies to Watch in 2020

VIDEO: Healthcare Technology Advances at CES 2019

Welcoming Apple to the World of ECG

Related Content

News | Wearables

May 18, 2022 — A new app developed by the Mayo Clinic transmits Apple Watch electrocardiograms (ECG) signals recorded in ...

Home May 18, 2022
Home
News | Wearables

May 4, 2022 – Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm ...

Home May 04, 2022
Home
News | Wearables

April 14, 2022 – Atrial fibrillation (AFib) was confirmed in nearly 94% of people who were initially identified to have ...

Home April 14, 2022
Home
News | Wearables
March 25, 2022 – Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate ...
Home March 25, 2022
Home
News | Wearables
March 1, 2022 – A new report says the wearable healthcare devices market is anticipated to grow at a CAGR of 13% from ...
Home March 01, 2022
Home
News | Wearables

Chenyang Lu, a professor of computer science and engineering, is marrying Fitbits with machine learning to predict which ...

Home February 09, 2022
Home
News | Wearables

January 7, 2022 — Abbott announced it is developing a new category of consumer biowearables called Lingo, which is being ...

Home January 07, 2022
Home
News | Wearables

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

Home November 18, 2021
Home
News | Wearables

November 1, 2021 — Health AI company Vagus.co, based in Cambridge, U.K., has launched a 30-second breathing test for ...

Home November 01, 2021
Home
News | Wearables

October 15, 2021 — Biotricity Inc. announced the release of Biocare Cardiac, a personal, cardiac health application for ...

Home October 15, 2021
Home
Subscribe Now